Studies have shown that γ-tocotrienol significantly reduced cyclin D1, cyclin-dependent kinases CDK4 and CDK6 levels between 4 and 24 h after EGF exposure in mammary cancer cells [49]. This evidence concerns the gene CCND1 and breast cancer.